Agile Therapeutics Inc (AGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,590 | 1,284 | -14,465 | -9,995 | -9,197 |
| Depreciation Amortization | 340 | 238 | 1,449 | 1,124 | 774 |
| Accounts receivable | -1,158 | -1,421 | -15 | -144 | -1,084 |
| Other Working Capital | 2,438 | -128 | 7,417 | 4,594 | 691 |
| Other Operating Activity | 6,727 | -2,449 | -3,963 | -5,328 | -1,298 |
| Operating Cash Flow | $-2,243 | $-2,476 | $-9,577 | $-9,749 | $-10,114 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,841 | -1,841 | -1,347 | -859 | -511 |
| Common Stock Issued | 4,376 | 4,376 | 8,235 | 8,234 | 8,164 |
| Financing Cash Flow | $2,535 | $2,535 | $6,888 | $7,375 | $7,653 |
| Beginning Cash Position | 2,556 | 2,556 | 5,246 | 5,246 | 5,246 |
| End Cash Position | 2,848 | 2,615 | 2,557 | 2,873 | 2,785 |
| Net Cash Flow | $292 | $59 | $-2,689 | $-2,374 | $-2,461 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,243 | -2,476 | -9,577 | -9,749 | -10,114 |
| Free Cash Flow | -2,243 | -2,476 | -9,577 | -9,749 | -10,114 |